Pfizer started injecting the third experimental dose of their kill shot, as Omicron pushes sales to another $50 billion!
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
“Pfizer-BioNTech announced Friday that they will expand ongoing clinical trials of their COVID-19 vaccine in children to include a third dose for participants as young as 6 months old,” NPR reporter.
“Testing a third dose will cause a delay in submission of data to regulators to authorize the use in the U.S. In the fall, Pfizer’s CEO said the company expected to have data for this age group by the end of 2021. Now, the company says that they would expect to file results in the “first half of 2022” if trials are successful.”
Consider the omicron variant and others presumably to follow, which could extend the pandemic. Then there’s the ineffectiveness of Regeneron and Eli Lilly antibody treatments against the new strain—and the declining potential of Merck & Co.’s oral antiviral to treat COVID-19.
The company stated two doses did not produce a robust immune response in kids 2 to 5 years old.